Dark Matter Therapeutics Inc. Inc
AI-driven phenotype-based discovery for more effective drugs in complex unmet medical conditions
Ce qui nous motive
Mission
Alter the Drug discovery paradigm from a target-centric one to an AI-driven phenotype based one.
Équipe
Membres de l'équipe
Steven Zimmer-co-founder and acting CEO Prof Lei Xie-Scientific Founder and acting CSO Yoyo Wu-AI Scientist-PhD student (April 2025)
Sur Foundersbase
Voir Dark Matter Therapeutics Inc. le profil complet de la société pour
- Identifier le potentiel de collaboration ou devenir membre de l'équipe
- En savoir plus sur "Dark Matter Therapeutics Inc. la vision et les offres de l'entreprise
- Se connecter et contacter "Dark Matter Therapeutics Inc. les fondateurs directement
Les gens ont aussi regardé
-
ByteStrike
Building the first regulated futures exchange for AI compute to enable hedging and price discovery
-
NEUROFIT
The NEUROFIT App is a minimalist performance-first wellness app for busy professionals.
-
Electron Fer
ElectronFer is revolutionizing energy systems with cutting-edge electron transfer technology
-
DeepNatures.com
wearable smart temp control module for human/humanoid/IDC